HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 51 filers reported holding HEPION PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.65 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $23,000 | -95.9% | 20,479 | -93.3% | 0.00% | -97.3% |
Q1 2021 | $564,000 | +216.9% | 306,338 | +434.5% | 0.11% | +307.4% |
Q3 2020 | $178,000 | +39.1% | 57,309 | -21.0% | 0.03% | -49.1% |
Q1 2020 | $128,000 | -54.0% | 72,575 | -36.9% | 0.05% | -64.7% |
Q3 2019 | $278,000 | – | 115,000 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 57,309 | $178,000 | 0.03% |
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 15,552 | $48,000 | 0.00% |
Squarepoint Ops LLC | 15,524 | $48,000 | 0.00% |
ExodusPoint Capital Management, LP | 11,632 | $36,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 33,215 | $103,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 57 | $0 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 15,786 | $49,000 | 0.00% |
MILLENNIUM MANAGEMENT LLC | 29,233 | $91,000 | 0.00% |
MORGAN STANLEY | 54 | $0 | 0.00% |